n.a. (DSCI)

0.00
NASDAQ
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NASDAQ
Div & Yield N.A. (N.A)
Derma Sciences To Present At The Canaccord Genuity Annual Growth Conference

Derma Sciences To Present At The Canaccord Genuity Annual Growth Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J.

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 14th

Derma Sciences To Hold Second Quarter Financial Results Conference Call On August 14th

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will hold a conference call on August 14, 2012 to discuss the financial ...

Derma Sciences Announces Issuance Of Two New U.S. Patents For DSC127

Derma Sciences Announces Issuance Of Two New U.S. Patents For DSC127

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the issuance of patents 8,207,233 and 8,207,234 by the U.

Derma Sciences Acquires Global Long-Term Exclusive Rights To NIMBUS Technology From Quick-Med Technologies

Derma Sciences Acquires Global Long-Term Exclusive Rights To NIMBUS Technology From Quick-Med Technologies

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc.

Derma Sciences Receives CE Mark For MEDIHONEY® HCS

Derma Sciences Receives CE Mark For MEDIHONEY® HCS

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for the Company’s patented MEDIHONEY® HCS (hydrogel colloidal sheet)...

Derma Sciences To Present At The 7th LHA Life Sciences & Medical Technologies Virtual Conference On June 28

Derma Sciences To Present At The 7th LHA Life Sciences & Medical Technologies Virtual Conference On June 28

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J.

Derma Sciences Announces Publication Of DSC127 Phase 2 Trial Results In Wound Repair And Regeneration

Derma Sciences Announces Publication Of DSC127 Phase 2 Trial Results In Wound Repair And Regeneration

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that full results from its successful Phase 2 clinical trial with the investigational...

Derma Sciences Added To The Russell 3000® Index

Derma Sciences Added To The Russell 3000® Index

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that its stock has been added the Russell 3000® Index.

5 Stocks That Make Prime Acquisition Targets

5 Stocks That Make Prime Acquisition Targets

These medical device firms could hold great appeal for the industry's larger players.

Derma Sciences Reports First Quarter 2012 Financial Results

Derma Sciences Reports First Quarter 2012 Financial Results

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three months ended March 31, 2012.

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 15

Derma Sciences To Hold First Quarter Financial Results Conference Call On May 15

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will hold a conference call on May 15, 2012 to discuss the financial ...

Derma Sciences Completes MedEfficiency Acquisition

Derma Sciences Completes MedEfficiency Acquisition

Derma Sciences, Inc. (Nasdaq: DSCI)(“Derma Sciences”), a medical device and pharmaceutical company focused on advanced wound care, has completed its previously announced acquisition of MedEfficiency, Inc.

Derma Sciences Closes $17.9 Million Underwritten Registered Direct Offering Of Common Stock

Derma Sciences Closes $17.9 Million Underwritten Registered Direct Offering Of Common Stock

Derma Sciences, Inc. (Nasdaq: DSCI) (the “Company”), a medical device and pharmaceutical company focused on advanced wound care, today announced that it closed an underwritten registered direct offering of ...

Derma Sciences To Present At The 11th Annual Needham Healthcare Conference

Derma Sciences To Present At The 11th Annual Needham Healthcare Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that Edward J.

Derma Sciences Announces Pricing Of Underwritten Registered Direct Offering Of Common Stock

Derma Sciences Announces Pricing Of Underwritten Registered Direct Offering Of Common Stock

Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of an underwritten registered direct offering of ...

Derma Sciences To Acquire MedEfficiency; Expands Proprietary Advanced Wound Care Product Offering With High-Growth, Market-Leading, Gold-Standard Treatment For Diabetic Foot Ulcers

Derma Sciences To Acquire MedEfficiency; Expands Proprietary Advanced Wound Care Product Offering With High-Growth, Market-Leading, Gold-Standard Treatment For Diabetic Foot Ulcers

Derma Sciences, Inc. (Nasdaq: DSCI)(“Derma Sciences”), a medical device and pharmaceutical company focused on advanced wound care, announces the signing of a definitive agreement to acquire MedEfficiency, Inc.

Derma Sciences Reports Record Fourth Quarter Net Sales; Sales Force Expansion Ahead Of Schedule; Continues Progress Toward Phase 3 Trials

Derma Sciences Reports Record Fourth Quarter Net Sales; Sales Force Expansion Ahead Of Schedule; Continues Progress Toward Phase 3 Trials

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and 12 months ended December 31, 2011.

Derma Sciences To Hold Fourth Quarter Financial Results Conference Call On March 29

Derma Sciences To Hold Fourth Quarter Financial Results Conference Call On March 29

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will hold a conference call on March 29, 2012 to discuss the financial ...

Derma Sciences Is Pleased To Have MEDIHONEY Recognized As A Finalist For Novation’s 2011 Innovative Technology Award

Derma Sciences Is Pleased To Have MEDIHONEY Recognized As A Finalist For Novation’s 2011 Innovative Technology Award

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that at the Novation Supplier Summit Conference in February the Company’s MEDIHONEY ...

Derma Sciences Meeting With FDA Supports Initiation Of Phase 3 Studies With DSC127 In Diabetic Foot Ulcers

Derma Sciences Meeting With FDA Supports Initiation Of Phase 3 Studies With DSC127 In Diabetic Foot Ulcers

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that it has discussed the results of the Company’s Phase 2 clinical study of the ...

Derma Sciences To Present At The LHA Life Sciences & Medtech Virtual Conference On February 16

Derma Sciences To Present At The LHA Life Sciences & Medtech Virtual Conference On February 16

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J.

Derma Sciences To Present At Upcoming Conferences

Derma Sciences To Present At Upcoming Conferences

In second paragraph, time should read 3:00 p.m.

Derma Sciences To Present At The Piper Jaffray 23rd Annual Healthcare Conference

Derma Sciences To Present At The Piper Jaffray 23rd Annual Healthcare Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will be presenting at the Piper Jaffray 23rd Annual Healthcare Conference...

3 Small-Cap Stocks on Insiders' Radar

3 Small-Cap Stocks on Insiders' Radar

Here are three stocks in which corporate insiders have been accumulating shares recently.

Derma Sciences Reports Third Quarter Financial And Operating Results; End-of-Phase 2 Meeting Set With FDA

Derma Sciences Reports Third Quarter Financial And Operating Results; End-of-Phase 2 Meeting Set With FDA

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and nine months ended September 30, 2011.

Derma Sciences To Present At The Lazard Capital Markets 8th Annual Healthcare Conference

Derma Sciences To Present At The Lazard Capital Markets 8th Annual Healthcare Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will be presenting at the Lazard Capital Markets 8th Annual Healthcare ...

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 11

Derma Sciences To Hold Third Quarter Financial Results Conference Call On November 11

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will hold a conference call on November 11, 2011 to discuss the financial...

Insiders Trading BBBY, ENTG, DSCI, CHKM

Insiders Trading BBBY, ENTG, DSCI, CHKM

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

Derma Sciences Launches MEDIHONEY® Gel At The Fall Symposium On Advanced Wound Care 2011

Derma Sciences Launches MEDIHONEY® Gel At The Fall Symposium On Advanced Wound Care 2011

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the launch of its latest formulation of MEDIHONEY ® , the .

Derma Sciences To Present At The Jefferies 2011 Global Healthcare Conference

Derma Sciences To Present At The Jefferies 2011 Global Healthcare Conference

Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care announced today that the Company will be presenting at the Jefferies 2011 Global Healthcare Conference on ...